Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Adient FY2026 Annual Report: 74.8M Shares Outstanding

Adient plc (NYSE:ADNT) filed its Annual Report on Form 10-K for the fiscal year ended September 30, 2026, disclosing operational and financial information for one of the automotive industry's largest global seating suppliers.

Shwetambri Chauhan | 13 November 2026

Legato Merger Corp. IV Files 10-K for Fiscal Year Ended August 31, 2026

Legato Merger Corp. IV filed its Annual Report on Form 10-K with the SEC on November 13, 2026, covering the fiscal year ended August 31, 2026, disclosing its status as a blank-check special purpose acquisition company listed on NYSE American.

Nitish Kishor | 13 November 2026

Freightos Gets Nasdaq Minimum Bid Price Warning

Freightos Limited disclosed in an 8-K equivalent press release on November 13, 2026, that it received a written notification letter from Nasdaq on November 10, 2026, citing non-compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.

Shwetambri Chauhan | 13 November 2026

FiEE Reports $9.6M Revenue, $3.6M Net Income for Nine Months 2026

FiEE, Inc. (NASDAQ:FIEE) released unaudited financial results for the three and nine months ended September 30, 2026, on November 13, 2026, reporting a 382.1% year-on-year revenue increase and a swing from net loss to net income for the nine-month period.

Aditi Sarkar | 13 November 2026

Invesco Mortgage Capital Declares $0.12 November 2026 Dividend

Invesco Mortgage Capital Inc. filed an 8-K on November 13, 2026, announcing a $0.12 per share cash dividend for November 2026 and disclosing preliminary, unaudited financial data as of October 31, 2026.

Aakashdeep | 13 November 2026

Montanova Capital Cuts Aura Biosciences Stake to 2.9%

Montanova Capital, LLC, Averill Master Fund, Ltd., and Aaron Cowen filed Amendment No. 2 to Schedule 13G with the SEC on November 13, 2026, disclosing their beneficial ownership of Aura Biosciences, Inc. common stock as of September 30, 2026.

Aditi Sarkar | 13 November 2026

Karpus Holds 18.37% Preferred Stake in Eagle Point Institutional

Karpus Management, Inc. filed Amendment No. 4 to its Schedule 13G on November 13, 2026, disclosing beneficial ownership of preferred shares in Eagle Point Institutional Income Fund as of September 30, 2026.

Nitish Kishor | 13 November 2026

CNO Financial Declares 59th Consecutive Quarterly Dividend

CNO Financial Group, Inc. filed an 8-K on November 13, 2026, announcing that its Board of Directors declared a quarterly cash dividend of $0.18 per share on the company's common shares, payable December 23, 2026.

Aakashdeep | 13 November 2026

Montanova Capital Discloses 8.9% Stake in Faeth Therapeutics

Montanova Capital, LLC, Averill Master Fund, Ltd., and Aaron Cowen filed a Schedule 13G Amendment No. 1 with the SEC on November 13, 2026, disclosing beneficial ownership positions in Faeth Therapeutics, Inc. common stock as of September 30, 2026.

Vinay Lochav | 13 November 2026

Karpus Management Discloses 9.46% Stake in Future Money Acquisition

Karpus Management, Inc. filed an amended Schedule 13G on November 13, 2026 with the SEC, disclosing beneficial ownership of 1,493,275 shares of common stock in Future Money Acquisition Corp. as of September 30, 2026.

Anjali Anand | 13 November 2026
Support

Hi! How can we help you today?

Loading…